Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion evidence source_evidence_literature NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion SIO_000772 16624621 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion wasDerivedFrom befree-20140225 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion wasGeneratedBy ECO_0000203 NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.